2[1]TOGUCHIDA J,YAMAGUCHI T,RtTCHIE B,et al.Mutation spectrum of the p53 gene in bone and soft tissue sarcoma[J].Cancer Res,1992,52:6194-6199.
3[2]WADAYAMA B,TOGUCHIDA,J,YAMAGUCHI T,et al.p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas[J].Br J Cancer,1993,68:1134-1139.
5[5]XIONG Y,HANMN G Y,ZHANG H,et al.p21 is a universal in 2 hibitor of cyclin kinases[J].Nature,1993,366:701-704.
6[6]LU W,LIN J,CHEN J.Expression of p14ARF overcomes tumor resistance to p53[J].Cancer Res,2002,62:1305-1310.
7[7]STOTR F J,BATES S A,JAMES M C.et al.The alternative product from the human CDKN2A locus,P14arf.participates in a regulator feedback loop with p53 and MDM2[J].EMBO J,1998,17(17):5001-5014.
8[9]LU W,LIN J,CHEN J.Expression of p14ARF overcomes tumor resistance to p53[J].Cancer Res,2002,62:1305-1310.
9[11]SERRANO M.The INK4a/ARF locus in murine tumorigenesis[J].Carcinogenesis,2000,21:865-869.
10[13]BOYLE J O,HAKIM J,KOCH W,et al.The inducidence of p53 mulations increase with progeression of head and neck cancer[J].Cancer Res,1993.53,4477-4480.
